As IFN-based strategies along with immune checkpoint inhibitors are putative therapeutic options for malignancies [4], therapeutic modulation of IFNG-AS1 expression would exert beneficial effects in cancer patients from diverse aspects. This evidence concerns the gene IFNG and cancer.